Private Management Group Inc Adamis Pharmaceuticals Corp Transaction History

Private Management Group Inc

  • $2.62 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$0.54 - $1.79 $5,670 - $18,795
-10,500 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$0.52 - $1.45 $5,460 - $15,225
10,500 New
10,500 $8,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Private Management Group Inc Portfolio

Follow Private Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email